Background Although plasma endothelin concentrations are elevated in patients with pulmonary hypertension, the precise sites of endothelin production have not been defined. We investigated the endothelin production in the pulmonary circulation of patients with mitral stenosis and its effects on pulmonary vascular tone.
Methods and Resuls We measured plasma concentrations of endothelin-1, angiotensin II, and thrombomodulin in blood samples obtained from the right and left atria of 10 consecutive patients with rheumatic mitral stenosis (mean age, 55 years; range, 39 to 68) who were undergoing percutaneous mitral valvuloplasty. Plasma levels of endothelin-1 were significantly higher in the left atrium than in the right atrium (3.25±0.45 versus 2.53+0.36 pg/mL, mean±SE, P<.001). The increased plasma endothelin-1 level in the left atrium, which reflected endothelin-1 production in the pulmonary circulation, was correlated with mean pulmonary artery pressure (r=.65, P=.04), mean pulmonary arterial wedge pressure (r=.67, P=.03), total pulmonary resistance (r=.68, P=.03), and 1/mitral valve area (r=.85, P=.002) but not with pulmonary vascular resistance (r=.04, P=.91). There were no significant differences in plasma levels of angiotensin II and thrombomodulin between the right and left atria (angiotensin II, 16 .40±3.08 versus 15.50±4.85 pg/mL; thrombomodulin, 2.96±0.34 versus 2.85 ±0.37 ng/mL).
Conclusions Endothelin-1 production is increased in the pulmonary circulation of patients with mitral stenosis in response to increased pulmonary artery pressure but is not directly related to increased pulmonary vascular tone in this disorder. (Circulon. 1994; 89:2093 -2098 Key Words * angiotensin II * thrombomodulin * atrium * valvuloplasty E ndothelin, an endothelium-derived peptide, has contractile and proliferative effects on vascular smooth muscle cells.1-4 Endothelin consists of 21 amino acid residues with two sets of intrachain disulfide linkages and is classified by its deduced amino acid sequences as three distinct isopeptides: endothelin-1, endothelin-2, and endothelin-3.5 Increased plasma endothelin concentrations have been observed in various cardiovascular disorders such as coronary spasm,6 acute myocardial infarction,7 essential hypertension,8-10 mitral stenosis,'1 cardiogenic shock,12 and subarachnoid hemorrhage. 13 Pulmonary hypertension refers to the abnormal hemodynamic effects of various conditions that lead to a chronic increase in pulmonary artery pressure and pulmonary vascular resistance. Chemical and hormonal regulation of pulmonary vascular resistance is a complex process. Catecholamine, acetylcholine, prostaglandin, histamine, bradykinin, serotonin, and angiotensin II have been found to play roles in the regulation of pulmonary vascular resistance.14 Recent studies have shown that plasma endothelin concentrations are elevated in patients with pulmonary hypertension,14-21 suggesting that endothelin is involved in the pathophysiology of pulmonary hypertension. Lippton et a122 reported that endothelin-1 induced contractions in isolated pulmonary vessels and increased pulmonary vas-cular resistance. Although evidence suggests increased endothelin production by pulmonary endothelial cells in pulmonary hypertension, the precise sites of endothelin production have not been defined.
Mitral stenosis is associated with increases in pulmonary artery pressure and resistance. We measured plasma levels of endothelin-1, angiotensin II, and thrombomodulin in right and left atrial blood samples obtained from 10 patients with rheumatic mitral stenosis who were undergoing percutaneous mitral valvuloplasty to determine whether endothelin-1 production is increased in the pulmonary circulation of patients with mitral stenosis.
Methods Subjects
We studied 10 patients with severe rheumatic mitral stenosis (9 with chronic atrial fibrillation and 1 with sinus rhythm) who underwent percutaneous mitral valvuloplasty using the 
Blood Sampling and Plasma Assay
Immediately before the valvuloplasty balloon was inflated, blood samples were obtained from the right and left atria through a thermodilution catheter (7F) and an Inoue balloon catheter (12F), respectively. A 6-mL sample of whole blood was drawn into a plastic tube containing 9 mg Na2-EDTA and 3000 KIU (kallidinogenase inactivator units) aprotinin for use in assays. All samples were placed on ice. Plasma was separated by prompt centrifugation of blood samples at 1800g at 40C for 20 minutes, immediately frozen, and stored at -80TC until needed for assays.
Plasma endothelin-1 was measured using a modification of a previously described radioimmunoassay.12 Samples were extracted using SepPak C18 cartridges (Waters) that had been activated with methanol, 8 mol/L urea, and water. Elution of endothelin-1 using 100% methanol yielded a recovery rate of 75±3.3%. Samples and standards (endothelin-1, Peptide Institute, Osaka, Japan) were reconstituted in the assay buffer and incubated for 24 hours with rabbit anti-endothelin-1 serum (Peninsula Laboratories, Belmont, Calif) at 4TC. This antibody primarily recognizes and has 100% cross-reactivity with endothelin-1. It also has 17% cross-reactivity with human big endothelin and 7% cross-reactivity with endothelin-2 and (Fig 1) . 
Correlation Between Hemodynamic Variables and Endothelin-1 Levels
The increase in plasma endothelin-1 levels between the left and right atria, reflecting endothelin-1 production in the pulmonary circulation, was significantly correlated with mean pulmonary artery pressure (r=.65, P=.04) (Fig 2) , mean pulmonary arterial wedge pressure (r=.67, P=.03), total pulmonary resistance (r=.68, P=.03), mean transmitral gradient (r=.63, P=.04), and 1/mitral valve area (r=.85, P=.002) ( Table  3) . However, the increase in endothelin-1 levels was not significantly correlated with pulmonary vascular resistance (r=.04, P=.91) (Fig 3) , cardiac index, or oxygen partial pressure in the aorta (Pao2) ( Table 3) . Plasma Angiotensin H and Thrombomodulin Levels
The plasma angiotensin II levels in peripheral vein blood samples obtained from normal subjects (14.2+2.2 pg/mL, n= 10) were not significantly different from right (16.40±3.08 pg/mL) and left atrial plasma levels (15.50±4.85 pg/mL) in patients with mitral stenosis. There was no significant difference in plasma angiotensin II levels between the right and left atria (Fig 4) .
Plasma thrombomodulin levels in peripheral vein blood samples obtained from normal subjects (3.20±0.30 ng/mL, in patients with mitral stenosis. There was no significant difference in plasma thrombomodulin levels between the right and left atria (Fig 5) .
Discussion
Plasma levels of endothelin-1 were significantly higher in the left atrium than in the right atrium in patients with mitral stenosis, and the increase in endothelin-1 levels in the left atrium was significantly correlated with mean pulmonary artery pressure but not with pulmonary vascular resistance, suggesting that endothelin-1 production is increased in the pulmonary circulation of patients with mitral stenosis in response to increased pulmonary artery pressure but is not directly related to increased pulmonary vascular tone in this disorder. In vitro and in vivo studies have demonstrated that endothelin is a potent constrictor of pulmonary arteries and veins but that it exerts a greater effect on pulmonary arteries.27 Endothelin has been found to increase pulmonary artery pressure in a time-dependent manner.2228 Yoshibayashi et al.' reported that plasma endothelin concentrations were significantly higher in subjects with congenital heart disease who had pulmonary hypertension than in subjects without pulmonary hypertension. Stewart et aP20 reported that plasma endothelin-1 levels were significantly higher in arterial plasma samples compared with venous plasma samples obtained from patients with primary pulmonary hypertension. Chang et al14 reported that plasma levels of endothelin-1 but not endothelin-3 were increased in patients with pulmonary hypertension. They speculated that both endothelin-1 and endothelin-3 were cleared mainly through the pulmonary circulation and that the constant level of endothelin-3 in plasma indicated that the clearance rate of endothelin in the lung was not impaired in patients with pulmonary hypertension.
Whether the elevated endothelin-1 in pulmonary hypertension contributes directly to increased pulmonary tone is controversial. Cody et al16 reported that elevated endothelin-1 concentrations in arterial plasma were correlated with hemodynamic variables such as pulmonary artery pressure and pulmonary vascular resistance in patients with congestive heart failure. On the other hand, Stewart et aP20 described that there was no correlation between endothelin-1 levels in venous or arterial plasma and pulmonary vascular resistance. In the present study, the increased levels of endothelin-1 in the pulmonary circulation of patients with mitral stenosis were not significantly correlated with pulmonary vascular resistance, suggesting that endothelin-1 production is not directly related to increased pulmonary vascular tone in this disorder.
The increase in plasma endothelin-1 levels also may be related to proliferation of the cells of the vessel wall in pulmonary hypertension. The morphology of the lungs in pulmonary venous hypertension associated with mitral valve disease is distinctive, and the veins, arteries, and parenchyma are affected. Medial hypertrophy and proliferation of smooth muscle cells are present in veins and arteries. Komuro et a12 reported that endothelin-1 caused proliferation of smooth muscle cells. Thus, increased secretion of endothelin-1 from endothelial cells may stimulate and further aggravate pathological changes in the underlying intima and media of the pulmonary vasculature in mitral stenosis.
The mechanism for increased endothelin-1 production in the pulmonary circulation of patients with mitral stenosis has not been clarified. Endothelin synthesis in endothelial cells is stimulated by epinephrine,1 thrombin,29 angiotensin jj,30 endotoxin,31,32 shear stress, 33 and hypoxia.34 '35 Shirakami et a134 showed that exposure to alveolar hypoxia increased endothelin levels in the plasma and lung in conscious unrestrained rats and that the increase of plasma and lung endothelin levels were paralleled to the severity of hypoxia. Elton et a135 reported that plasma endothelin-1 levels in rats were increased significantly during 48 hours of hypoxia (10% 02) compared with air controls and that endothelin-1 mRNA levels were increased twofold in the lung and right atrium after 48 hours of hypoxia. However, in our study, plasma levels of endothelin-1 in the right and left atria and the increase in endothelin-1 levels from the right atrium to the left atrium were not related to Pao2 levels.
On the other hand, Vincent et all8 found that endothelin levels were increased in patients with congenital heart disease associated with left-to-right shunts and that the increase was related to increased pulmonary blood flow and was independent of pulmonary artery pressure. In our study, the increase in endothelin-1 concentrations from the right atrium to the left atrium was not correlated with cardiac index, suggesting that the increased endothelin-1 production is not related to pulmonary blood flow. Recently, Yoshizumi et a133 reported that hemodynamic low shear stress stimulated the expression of endothelin mRNA in endothelial cells with an increased release of immunoreactive endothelin into the culture medium. In the present study, the increased levels of endothelin-1 in the pulmonary circulation of patients with mitral stenosis were significantly correlated with mean pulmonary artery pressure, supporting the premise that abnormal hemodynamic forces such as high pressure on pulmonary artery walls may stimulate endothelin-1 production by pulmonary artery endothelial cells.
Angiotensin II has vasoconstrictive effects similar to those of endothelin and stimulates the growth of vascular smooth muscle cells and endothelin-1 synthesis in endothelial cells. 30 Angiotensin II has been implicated in hypoxia-induced pulmonary hypertension.36-38 However, Cassis et a139 reported that angiotensin II did not contribute to pulmonary hypertension in rats treated with the pyrrolizidine alkaloid monocrotaline. We observed no significant increase in plasma levels of angiotensin II in the right atrium or the left atrium, suggesting that angiotensin II did not contribute to increased vascular resistance and endothelin-1 production in mitral stenosis.
Thrombomodulin is a high-affinity thrombin receptor present on vascular endothelial cells, placental syncytiotrophoblasts, and platelets.404l It is a cofactor for thrombin-catalyzed activation of the anticoagulant protease zymogen protein C. Thrombomodulin has been detected in the circulating blood after endothelial injury.4042 Plasma thrombomodulin levels are elevated in various conditions such as diabetes mellitus,43 hemodialysis,4 systemic lupus erythematosus, thrombotic thrombocytopenic purpura, and disseminated intravascular coagulation. 45 Karmochkine et aW46 reported that plasma thrombomodulin levels were decreased in patients with pulmonary hypertension compared with control subjects. We observed a tendency toward decreased plasma thrombomodulin levels in both atria compared with peripheral vein of normal subjects, although there was no significant difference between the right and left atria. This observation suggests that increased plasma levels of endothelin-1 may not result from leakage of the peptide from injured endothelial cells but are likely to be related to increased biosynthesis in pulmonary endothelial cells.
Our results show that endothelin-1 production is significantly increased in the pulmonary circulation of patients with mitral stenosis in response to increased pulmonary artery pressure. However, there was no evidence to implicate circulating endothelin-1 in the pathogenesis of pulmonary hypertension in this disorder. Further studies are needed to clarify the pathophysiological role of endothelin-1 in pulmonary hemodynamics in vivo.
